drugset

Drugs / GRIDEGALUTAMIDE

Follow last change Oct 2025 re-read 2 minutes ago

GRIDEGALUTAMIDE

also known as BMS-986409 · CC-94676, (3R)- · CC1083611 · CEL-010355 · Gridegalutamida

Investigated by: Celgene Corporation

Trials 1 · a red edge is where a trial was stopped

today NCT06433505 · Ph 1

20252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT06433505	May 2024 → Feb 2025	—	Celgene Corporation	Completed	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT04428788 Background	Jun 2020 → Oct 2025	prostate neoplasm	Celgene Corporation	Completed	No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	GRIDEGALUTAMIDE	ChEMBL registry synonym — accepted as the source's own label CHEMBL6068413 ↗
Known as	BMS-986409	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06433505 ↗
Known as	CC-94676, (3R)-	ChEMBL registry synonym — accepted as the source's own label CHEMBL6068413 ↗
Known as	CC1083611	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04428788 ↗
Known as	CEL-010355	ChEMBL registry synonym — accepted as the source's own label CHEMBL6068413 ↗
Known as	Gridegalutamida	ChEMBL registry synonym — accepted as the source's own label CHEMBL6068413 ↗
Modality	Small molecule	— CHEMBL6068413 ↗